Pharma Engineering ApS

CVR 42133590 · Private limited company (ApS) · Active · Medium risk

Pharma Engineering ApS is a Private limited company (ApS), founded on , based in Roskilde. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 2.3% over the next 12 months, which is 1.6 times the average for Danish companies. 5 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 51k and a net result of DKK 6,370. CEO: Mads Mose Onsberg.

Bankruptcy risk for Pharma Engineering ApS

2.3%
probability of bankruptcy within 12 months
Medium risk

1.6 × the average (1.41%) · higher risk than 84% of active Danish companies

Lowest riskHighest risk

Increases the risk

CEO's previous bankruptcies3+ · bankruptcy rate 20.2%2.3×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Equity vs. share capital1× · bankruptcy rate 12.9%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
42133590
Status
Active
Company type
Private limited company (ApS)
Founded
(5 years)
Address
Tokhøjvej 34
4000 Roskilde
Municipality
Roskilde
Industry
Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber
Share capital
DKK 40k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 5
Missing annual reportNo
Negative equityNo
Equity ratio100.0%
Current ratio–
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies4
Other companies at the address4
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK 0DKK 0DKK 0
Net profitDKK 6,370DKK 1,475DKK -4,394
EquityDKK 51kDKK 45kDKK 43k
Total assetsDKK 51kDKK 45kDKK 43k
Avg. employees00–

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025173
1 Jan 2024 – 31 Dec 2024114
1 Jan 2023 – 31 Dec 2023146
1 Jan 2022 – 31 Dec 2022174
14 Feb 2021 – 31 Dec 2021179

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOMads Mose OnsbergCurrent
Owner (100%)Mads Mose OnsbergCurrent
FounderMads Mose OnsbergCurrent

The CEOs' other companies

Mads Mose Onsberg – 12 other companies, of which 8 bankrupt

Address history (0 moves)

Tokhøjvej 34, 4000 Roskilde

Former names

Pharma Engineering ApS – now
Mose Holding ApS –

Other companies at the same address

Similar companies in Roskilde

Questions and answers about Pharma Engineering ApS

Has Pharma Engineering ApS gone bankrupt?

No, Pharma Engineering ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Pharma Engineering ApS?

Our model estimates a bankruptcy risk of 2.3% over the next 12 months (medium risk), which is 1.6 times the average for Danish companies.

Who is the CEO of Pharma Engineering ApS?

Mads Mose Onsberg is the CEO of Pharma Engineering ApS.

When was Pharma Engineering ApS founded?

Pharma Engineering ApS was founded on 14 February 2021.

What is the equity of Pharma Engineering ApS?

Equity was DKK 51k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.